APO Research

APO RESEARCH · REPORT

Vertebroplasty Stent System

Selected research

Industry Research

Vertebroplasty Stent System Industry Research Report 2026

Market perspective

The global Vertebroplasty Stent System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Vertebroplasty Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Vertebroplasty Stent System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Vertebroplasty Stent System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Vertebroplasty Stent System include Tianjin Zhengtian Medical Equipment Co., Ltd., Andtosi, Shanghai Sanyou Medical Co.,ltd., Shandong Weigao Orthopaedic Device Co.,ltd., Johnson & Johnson, Ningbo HicRen Biotechnology Co., Ltd, Medtronic, Double Medical Technology Inc. and Double Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Vertebroplasty Stent System market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Vertebroplasty Stent System Market by Company

Tianjin Zhengtian Medical Equipment Co., Ltd.

Andtosi

Shanghai Sanyou Medical Co.,ltd.

Shandong Weigao Orthopaedic Device Co.,ltd.

Johnson & Johnson

Ningbo HicRen Biotechnology Co., Ltd

Medtronic

Double Medical Technology Inc.

Double Medical

Zimmer Biomet

Teknimed

Stryker

Spine Wave

NuVasive

MicroPort

Merit Medical

Globus Medical

Vertebroplasty Stent System Segment by Type

Vertebroplasty Brace

Kyphoplasty Brace

Vertebroplasty Stent System Segment by Application

Hospital

Clinic

Vertebroplasty Stent System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vertebroplasty Stent System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vertebroplasty Stent System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vertebroplasty Stent System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Vertebroplasty Stent System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Vertebroplasty Stent System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Vertebroplasty Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vertebroplasty Stent System Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Vertebroplasty Stent System Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Vertebroplasty Stent System Sales Market Share by Manufacturers (2021-2026) Table 8. Global Vertebroplasty Stent System Revenue of Manufacturers (2021-2026) Table 9. Global Vertebroplasty Stent System Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Vertebroplasty Stent System Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Vertebroplasty Stent System Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Vertebroplasty Stent System, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Vertebroplasty Stent System, Product Type & Application Table 14. Global Vertebroplasty Stent System Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Vertebroplasty Stent System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Tianjin Zhengtian Medical Equipment Co., Ltd. Company Information Table 19. Tianjin Zhengtian Medical Equipment Co., Ltd. Business Overview Table 20. Tianjin Zhengtian Medical Equipment Co., Ltd. Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Tianjin Zhengtian Medical Equipment Co., Ltd. Vertebroplasty Stent System Product Portfolio Table 22. Tianjin Zhengtian Medical Equipment Co., Ltd. Recent Developments Table 23. Andtosi Company Information Table 24. Andtosi Business Overview Table 25. Andtosi Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Andtosi Vertebroplasty Stent System Product Portfolio Table 27. Andtosi Recent Developments Table 28. Shanghai Sanyou Medical Co.,ltd. Company Information Table 29. Shanghai Sanyou Medical Co.,ltd. Business Overview Table 30. Shanghai Sanyou Medical Co.,ltd. Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shanghai Sanyou Medical Co.,ltd. Vertebroplasty Stent System Product Portfolio Table 32. Shanghai Sanyou Medical Co.,ltd. Recent Developments Table 33. Shandong Weigao Orthopaedic Device Co.,ltd. Company Information Table 34. Shandong Weigao Orthopaedic Device Co.,ltd. Business Overview Table 35. Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty Stent System Product Portfolio Table 37. Shandong Weigao Orthopaedic Device Co.,ltd. Recent Developments Table 38. Johnson & Johnson Company Information Table 39. Johnson & Johnson Business Overview Table 40. Johnson & Johnson Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Johnson & Johnson Vertebroplasty Stent System Product Portfolio Table 42. Johnson & Johnson Recent Developments Table 43. Ningbo HicRen Biotechnology Co., Ltd Company Information Table 44. Ningbo HicRen Biotechnology Co., Ltd Business Overview Table 45. Ningbo HicRen Biotechnology Co., Ltd Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Ningbo HicRen Biotechnology Co., Ltd Vertebroplasty Stent System Product Portfolio Table 47. Ningbo HicRen Biotechnology Co., Ltd Recent Developments Table 48. Medtronic Company Information Table 49. Medtronic Business Overview Table 50. Medtronic Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Medtronic Vertebroplasty Stent System Product Portfolio Table 52. Medtronic Recent Developments Table 53. Double Medical Technology Inc. Company Information Table 54. Double Medical Technology Inc. Business Overview Table 55. Double Medical Technology Inc. Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Double Medical Technology Inc. Vertebroplasty Stent System Product Portfolio Table 57. Double Medical Technology Inc. Recent Developments Table 58. Double Medical Company Information Table 59. Double Medical Business Overview Table 60. Double Medical Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Double Medical Vertebroplasty Stent System Product Portfolio Table 62. Double Medical Recent Developments Table 63. Zimmer Biomet Company Information Table 64. Zimmer Biomet Business Overview Table 65. Zimmer Biomet Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zimmer Biomet Vertebroplasty Stent System Product Portfolio Table 67. Zimmer Biomet Recent Developments Table 68. Teknimed Company Information Table 69. Teknimed Business Overview Table 70. Teknimed Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Teknimed Vertebroplasty Stent System Product Portfolio Table 72. Teknimed Recent Developments Table 73. Stryker Company Information Table 74. Stryker Business Overview Table 75. Stryker Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Stryker Vertebroplasty Stent System Product Portfolio Table 77. Stryker Recent Developments Table 78. Spine Wave Company Information Table 79. Spine Wave Business Overview Table 80. Spine Wave Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Spine Wave Vertebroplasty Stent System Product Portfolio Table 82. Spine Wave Recent Developments Table 83. NuVasive Company Information Table 84. NuVasive Business Overview Table 85. NuVasive Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. NuVasive Vertebroplasty Stent System Product Portfolio Table 87. NuVasive Recent Developments Table 88. MicroPort Company Information Table 89. MicroPort Business Overview Table 90. MicroPort Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. MicroPort Vertebroplasty Stent System Product Portfolio Table 92. MicroPort Recent Developments Table 93. Merit Medical Company Information Table 94. Merit Medical Business Overview Table 95. Merit Medical Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Merit Medical Vertebroplasty Stent System Product Portfolio Table 97. Merit Medical Recent Developments Table 98. Globus Medical Company Information Table 99. Globus Medical Business Overview Table 100. Globus Medical Vertebroplasty Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Globus Medical Vertebroplasty Stent System Product Portfolio Table 102. Globus Medical Recent Developments Table 103. Global Vertebroplasty Stent System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Vertebroplasty Stent System Sales by Region (2021-2026) & (K Units) Table 105. Global Vertebroplasty Stent System Sales Market Share by Region (2021-2026) Table 106. Global Vertebroplasty Stent System Sales by Region (2027-2032) & (K Units) Table 107. Global Vertebroplasty Stent System Sales Market Share by Region (2027-2032) Table 108. Global Vertebroplasty Stent System Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Vertebroplasty Stent System Revenue Market Share by Region (2021-2026) Table 110. Global Vertebroplasty Stent System Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Vertebroplasty Stent System Revenue Market Share by Region (2027-2032) Table 112. North America Vertebroplasty Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Vertebroplasty Stent System Sales by Country (2021-2026) & (K Units) Table 114. North America Vertebroplasty Stent System Sales by Country (2027-2032) & (K Units) Table 115. North America Vertebroplasty Stent System Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Vertebroplasty Stent System Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Vertebroplasty Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Vertebroplasty Stent System Sales by Country (2021-2026) & (K Units) Table 119. Europe Vertebroplasty Stent System Sales by Country (2027-2032) & (K Units) Table 120. Europe Vertebroplasty Stent System Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Vertebroplasty Stent System Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Vertebroplasty Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Vertebroplasty Stent System Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Vertebroplasty Stent System Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Vertebroplasty Stent System Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Vertebroplasty Stent System Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Vertebroplasty Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Vertebroplasty Stent System Sales by Country (2021-2026) & (K Units) Table 129. South America Vertebroplasty Stent System Sales by Country (2027-2032) & (K Units) Table 130. South America Vertebroplasty Stent System Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Vertebroplasty Stent System Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Vertebroplasty Stent System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Vertebroplasty Stent System Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Vertebroplasty Stent System Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Vertebroplasty Stent System Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Vertebroplasty Stent System Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Vertebroplasty Stent System Sales by Type (2021-2026) & (K Units) Table 138. Global Vertebroplasty Stent System Sales by Type (2027-2032) & (K Units) Table 139. Global Vertebroplasty Stent System Sales Market Share by Type (2021-2026) Table 140. Global Vertebroplasty Stent System Sales Market Share by Type (2027-2032) Table 141. Global Vertebroplasty Stent System Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Vertebroplasty Stent System Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Vertebroplasty Stent System Revenue Market Share by Type (2021-2026) Table 144. Global Vertebroplasty Stent System Revenue Market Share by Type (2027-2032) Table 145. Global Vertebroplasty Stent System Price by Type (2021-2026) & (US$/Unit) Table 146. Global Vertebroplasty Stent System Price by Type (2027-2032) & (US$/Unit) Table 147. Global Vertebroplasty Stent System Sales by Application (2021-2026) & (K Units) Table 148. Global Vertebroplasty Stent System Sales by Application (2027-2032) & (K Units) Table 149. Global Vertebroplasty Stent System Sales Market Share by Application (2021-2026) Table 150. Global Vertebroplasty Stent System Sales Market Share by Application (2027-2032) Table 151. Global Vertebroplasty Stent System Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Vertebroplasty Stent System Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Vertebroplasty Stent System Revenue Market Share by Application (2021-2026) Table 154. Global Vertebroplasty Stent System Revenue Market Share by Application (2027-2032) Table 155. Global Vertebroplasty Stent System Price by Application (2021-2026) & (US$/Unit) Table 156. Global Vertebroplasty Stent System Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Vertebroplasty Stent System Distributors List Table 160. Vertebroplasty Stent System Customers List Table 161. Vertebroplasty Stent System Industry Trends Table 162. Vertebroplasty Stent System Industry Drivers Table 163. Vertebroplasty Stent System Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Vertebroplasty Stent System Product Image Figure 5. Global Vertebroplasty Stent System Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Vertebroplasty Stent System Market Size (2021-2032) & (US$ Million) Figure 7. Global Vertebroplasty Stent System Sales (2021-2032) & (K Units) Figure 8. Global Vertebroplasty Stent System Average Price (US$/Unit) & (2021-2032) Figure 9. Vertebroplasty Brace Product Image Figure 10. Kyphoplasty Brace Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Vertebroplasty Stent System Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Vertebroplasty Stent System, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Vertebroplasty Stent System Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Vertebroplasty Stent System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Vertebroplasty Stent System Sales by Region in 2025 Figure 19. Global Vertebroplasty Stent System Revenue by Region in 2025 Figure 20. North America Vertebroplasty Stent System Market Size by Country in 2025 Figure 21. North America Vertebroplasty Stent System Sales Market Share by Country (2021-2032) Figure 22. North America Vertebroplasty Stent System Revenue Market Share by Country (2021-2032) Figure 23. United States Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Vertebroplasty Stent System Market Size by Country in 2025 Figure 27. Europe Vertebroplasty Stent System Sales Market Share by Country (2021-2032) Figure 28. Europe Vertebroplasty Stent System Revenue Market Share by Country (2021-2032) Figure 29. Germany Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Vertebroplasty Stent System Market Size by Country in 2025 Figure 40. Asia Pacific Vertebroplasty Stent System Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Vertebroplasty Stent System Revenue Market Share by Country (2021-2032) Figure 42. China Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Vertebroplasty Stent System Market Size by Country in 2025 Figure 51. South America Vertebroplasty Stent System Sales Market Share by Country (2021-2032) Figure 52. South America Vertebroplasty Stent System Revenue Market Share by Country (2021-2032) Figure 53. Brazil Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Vertebroplasty Stent System Market Size by Country in 2025 Figure 57. Middle East and Africa Vertebroplasty Stent System Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Vertebroplasty Stent System Revenue Market Share by Country (2021-2032) Figure 59. Egypt Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Vertebroplasty Stent System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Vertebroplasty Stent System Sales Market Share by Type (2021-2032) Figure 65. Global Vertebroplasty Stent System Revenue Market Share by Type (2021-2032) Figure 66. Global Vertebroplasty Stent System Price (US$/Unit) by Type (2021-2032) Figure 67. Global Vertebroplasty Stent System Sales Market Share by Application (2021-2032) Figure 68. Global Vertebroplasty Stent System Revenue Market Share by Application (2021-2032) Figure 69. Global Vertebroplasty Stent System Price (US$/Unit) by Application (2021-2032) Figure 70. Vertebroplasty Stent System Value Chain Figure 71. Vertebroplasty Stent System Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Vertebroplasty Stent System Industry Opportunities and Challenges

Scope & coverage.

Types
  • Vertebroplasty Brace
  • Kyphoplasty Brace
Applications
  • Hospital
  • Clinic
Companies covered
  • Tianjin Zhengtian Medical Equipment Co., Ltd.
  • Andtosi
  • Shanghai Sanyou Medical Co.,ltd.
  • Shandong Weigao Orthopaedic Device Co.,ltd.
  • Johnson & Johnson
  • Ningbo HicRen Biotechnology Co., Ltd
  • Medtronic
  • Double Medical Technology Inc.
  • Double Medical
  • Zimmer Biomet
  • Teknimed
  • Stryker
  • Spine Wave
  • NuVasive
  • MicroPort
  • Merit Medical
  • Globus Medical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Vertebroplasty Stent System Market Size (2021-2032)
  4. 2.2.2 Global Vertebroplasty Stent System Sales (2021-2032)
  5. 2.2.3 Global Vertebroplasty Stent System Market Average Price (2021-2032)
  6. 2.3 Vertebroplasty Stent System by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Vertebroplasty Brace
  9. 2.3.3 Kyphoplasty Brace
  10. 2.4 Vertebroplasty Stent System by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Vertebroplasty Stent System Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Vertebroplasty Stent System Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Vertebroplasty Stent System Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Vertebroplasty Stent System Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Vertebroplasty Stent System Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Vertebroplasty Stent System, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Vertebroplasty Stent System, Product Type & Application
  8. 3.8 Global Manufacturers of Vertebroplasty Stent System, Established Date
  9. 3.9 Global Vertebroplasty Stent System Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Tianjin Zhengtian Medical Equipment Co., Ltd.
  2. 4.1.1 Tianjin Zhengtian Medical Equipment Co., Ltd. Company Information
  3. 4.1.2 Tianjin Zhengtian Medical Equipment Co., Ltd. Business Overview
  4. 4.1.3 Tianjin Zhengtian Medical Equipment Co., Ltd. Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Tianjin Zhengtian Medical Equipment Co., Ltd. Vertebroplasty Stent System Product Portfolio
  6. 4.1.5 Tianjin Zhengtian Medical Equipment Co., Ltd. Recent Developments
  7. 4.2 Andtosi
  8. 4.2.1 Andtosi Company Information
  9. 4.2.2 Andtosi Business Overview
  10. 4.2.3 Andtosi Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Andtosi Vertebroplasty Stent System Product Portfolio
  12. 4.2.5 Andtosi Recent Developments
  13. 4.3 Shanghai Sanyou Medical Co.,ltd.
  14. 4.3.1 Shanghai Sanyou Medical Co.,ltd. Company Information
  15. 4.3.2 Shanghai Sanyou Medical Co.,ltd. Business Overview
  16. 4.3.3 Shanghai Sanyou Medical Co.,ltd. Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shanghai Sanyou Medical Co.,ltd. Vertebroplasty Stent System Product Portfolio
  18. 4.3.5 Shanghai Sanyou Medical Co.,ltd. Recent Developments
  19. 4.4 Shandong Weigao Orthopaedic Device Co.,ltd.
  20. 4.4.1 Shandong Weigao Orthopaedic Device Co.,ltd. Company Information
  21. 4.4.2 Shandong Weigao Orthopaedic Device Co.,ltd. Business Overview
  22. 4.4.3 Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shandong Weigao Orthopaedic Device Co.,ltd. Vertebroplasty Stent System Product Portfolio
  24. 4.4.5 Shandong Weigao Orthopaedic Device Co.,ltd. Recent Developments
  25. 4.5 Johnson & Johnson
  26. 4.5.1 Johnson & Johnson Company Information
  27. 4.5.2 Johnson & Johnson Business Overview
  28. 4.5.3 Johnson & Johnson Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Johnson & Johnson Vertebroplasty Stent System Product Portfolio
  30. 4.5.5 Johnson & Johnson Recent Developments
  31. 4.6 Ningbo HicRen Biotechnology Co., Ltd
  32. 4.6.1 Ningbo HicRen Biotechnology Co., Ltd Company Information
  33. 4.6.2 Ningbo HicRen Biotechnology Co., Ltd Business Overview
  34. 4.6.3 Ningbo HicRen Biotechnology Co., Ltd Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ningbo HicRen Biotechnology Co., Ltd Vertebroplasty Stent System Product Portfolio
  36. 4.6.5 Ningbo HicRen Biotechnology Co., Ltd Recent Developments
  37. 4.7 Medtronic
  38. 4.7.1 Medtronic Company Information
  39. 4.7.2 Medtronic Business Overview
  40. 4.7.3 Medtronic Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Medtronic Vertebroplasty Stent System Product Portfolio
  42. 4.7.5 Medtronic Recent Developments
  43. 4.8 Double Medical Technology Inc.
  44. 4.8.1 Double Medical Technology Inc. Company Information
  45. 4.8.2 Double Medical Technology Inc. Business Overview
  46. 4.8.3 Double Medical Technology Inc. Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Double Medical Technology Inc. Vertebroplasty Stent System Product Portfolio
  48. 4.8.5 Double Medical Technology Inc. Recent Developments
  49. 4.9 Double Medical
  50. 4.9.1 Double Medical Company Information
  51. 4.9.2 Double Medical Business Overview
  52. 4.9.3 Double Medical Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Double Medical Vertebroplasty Stent System Product Portfolio
  54. 4.9.5 Double Medical Recent Developments
  55. 4.10 Zimmer Biomet
  56. 4.10.1 Zimmer Biomet Company Information
  57. 4.10.2 Zimmer Biomet Business Overview
  58. 4.10.3 Zimmer Biomet Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Zimmer Biomet Vertebroplasty Stent System Product Portfolio
  60. 4.10.5 Zimmer Biomet Recent Developments
  61. 4.11 Teknimed
  62. 4.11.1 Teknimed Company Information
  63. 4.11.2 Teknimed Business Overview
  64. 4.11.3 Teknimed Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Teknimed Vertebroplasty Stent System Product Portfolio
  66. 4.11.5 Teknimed Recent Developments
  67. 4.12 Stryker
  68. 4.12.1 Stryker Company Information
  69. 4.12.2 Stryker Business Overview
  70. 4.12.3 Stryker Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Stryker Vertebroplasty Stent System Product Portfolio
  72. 4.12.5 Stryker Recent Developments
  73. 4.13 Spine Wave
  74. 4.13.1 Spine Wave Company Information
  75. 4.13.2 Spine Wave Business Overview
  76. 4.13.3 Spine Wave Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Spine Wave Vertebroplasty Stent System Product Portfolio
  78. 4.13.5 Spine Wave Recent Developments
  79. 4.14 NuVasive
  80. 4.14.1 NuVasive Company Information
  81. 4.14.2 NuVasive Business Overview
  82. 4.14.3 NuVasive Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 NuVasive Vertebroplasty Stent System Product Portfolio
  84. 4.14.5 NuVasive Recent Developments
  85. 4.15 MicroPort
  86. 4.15.1 MicroPort Company Information
  87. 4.15.2 MicroPort Business Overview
  88. 4.15.3 MicroPort Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 MicroPort Vertebroplasty Stent System Product Portfolio
  90. 4.15.5 MicroPort Recent Developments
  91. 4.16 Merit Medical
  92. 4.16.1 Merit Medical Company Information
  93. 4.16.2 Merit Medical Business Overview
  94. 4.16.3 Merit Medical Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Merit Medical Vertebroplasty Stent System Product Portfolio
  96. 4.16.5 Merit Medical Recent Developments
  97. 4.17 Globus Medical
  98. 4.17.1 Globus Medical Company Information
  99. 4.17.2 Globus Medical Business Overview
  100. 4.17.3 Globus Medical Vertebroplasty Stent System Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Globus Medical Vertebroplasty Stent System Product Portfolio
  102. 4.17.5 Globus Medical Recent Developments
5 Global Vertebroplasty Stent System Market Scenario by Region
  1. 5.1 Global Vertebroplasty Stent System Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Vertebroplasty Stent System Sales by Region: 2021-2032
  3. 5.2.1 Global Vertebroplasty Stent System Sales by Region: 2021-2026
  4. 5.2.2 Global Vertebroplasty Stent System Sales by Region: 2027-2032
  5. 5.3 Global Vertebroplasty Stent System Revenue by Region: 2021-2032
  6. 5.3.1 Global Vertebroplasty Stent System Revenue by Region: 2021-2026
  7. 5.3.2 Global Vertebroplasty Stent System Revenue by Region: 2027-2032
  8. 5.4 North America Vertebroplasty Stent System Market Facts & Figures by Country
  9. 5.4.1 North America Vertebroplasty Stent System Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Vertebroplasty Stent System Sales by Country (2021-2032)
  11. 5.4.3 North America Vertebroplasty Stent System Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Vertebroplasty Stent System Market Facts & Figures by Country
  16. 5.5.1 Europe Vertebroplasty Stent System Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Vertebroplasty Stent System Sales by Country (2021-2032)
  18. 5.5.3 Europe Vertebroplasty Stent System Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Vertebroplasty Stent System Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Vertebroplasty Stent System Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Vertebroplasty Stent System Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Vertebroplasty Stent System Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Vertebroplasty Stent System Market Facts & Figures by Country
  41. 5.7.1 South America Vertebroplasty Stent System Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Vertebroplasty Stent System Sales by Country (2021-2032)
  43. 5.7.3 South America Vertebroplasty Stent System Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Vertebroplasty Stent System Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Vertebroplasty Stent System Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Vertebroplasty Stent System Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Vertebroplasty Stent System Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Vertebroplasty Stent System Sales by Type (2021-2032)
  2. 6.1.1 Global Vertebroplasty Stent System Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Vertebroplasty Stent System Sales Market Share by Type (2021-2032)
  4. 6.2 Global Vertebroplasty Stent System Revenue by Type (2021-2032)
  5. 6.2.1 Global Vertebroplasty Stent System Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Vertebroplasty Stent System Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Vertebroplasty Stent System Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Vertebroplasty Stent System Sales by Application (2021-2032)
  2. 7.1.1 Global Vertebroplasty Stent System Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Vertebroplasty Stent System Sales Market Share by Application (2021-2032)
  4. 7.2 Global Vertebroplasty Stent System Revenue by Application (2021-2032)
  5. 7.2.1 Global Vertebroplasty Stent System Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Vertebroplasty Stent System Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Vertebroplasty Stent System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Vertebroplasty Stent System Value Chain Analysis
  2. 8.1.1 Vertebroplasty Stent System Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Vertebroplasty Stent System Production Mode & Process
  5. 8.2 Vertebroplasty Stent System Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Vertebroplasty Stent System Distributors
  8. 8.2.3 Vertebroplasty Stent System Customers
9 Global Vertebroplasty Stent System Analyzing Market Dynamics
  1. 9.1 Vertebroplasty Stent System Industry Trends
  2. 9.2 Vertebroplasty Stent System Industry Drivers
  3. 9.3 Vertebroplasty Stent System Industry Opportunities and Challenges
  4. 9.4 Vertebroplasty Stent System Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research